Eye disease drug firm Aerie Pharma acquires Spanish company for $10M | WRAL TechWire
Rise in the sentiment of investors in Aerie Pharmaceuticals INC. – Medgazette 24
Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Program
Aerie Pharma on go with mid-stage study of eye drop for dry eye (NASDAQ:AERI) | Seeking Alpha
Aerie Pharma (AERI) Provides 2020 Company and Guidance Update Associated with COVID-19
Aerie Pharmaceuticals (AERI) Investor Presentation - Slideshow (NASDAQ:AERI) | Seeking Alpha
Investor Relations | Aerie Pharmaceuticals, Inc
SEC Filings | Aerie Pharmaceuticals, Inc
Aerie Pharmaceuticals to Present at Two Investor Conferences in March | Business Wire
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Aerie Pharmaceuticals – Capital Sign Solutions
Aerie Pharma: Finding Value In The Ophthalmic Space (NASDAQ:AERI) | Seeking Alpha
Aerie Pharma: Significantly Derisked (NASDAQ:AERI) | Seeking Alpha
Aerie Pharma's CMO Receives FDA CRL - Contract Pharma
Aerie in Europe - EuroTimes
Aerie Pharma to use DSM polymers to develop eye drug delivery tech
FDA OK of Aerie Pharma glaucoma drug jeopardized by factory issues out of its control
Aerie Pharmaceuticals Inc (AERI) Q3 2020 Earnings Call Transcript
AERIE PHARMACEUTICALS, INC. : AERI Stock Price | MarketScreener
Ophthalmology Innovation Showcase 1 - Aerie Pharmaceuticals
Aerie-Pharma -
Durham-based Aerie Pharma sees positive study results for eye pressure drug | WRAL TechWire
Aerie Pharmaceuticals Inc - AnnualReports.com
